Research for the Improvement in Measurement Methods and the Effect of Sodium Intake on Cardiovascular Health

January 21, 2013 updated by: Moo-Yong Rhee, DongGuk University

Sodium Intake: Research for the Improvement in Measurement Methods and the Effect of Sodium Intake on Cardiovascular Health

Epidemiological, clinical and animal-experimental evidence shows a direct relationship between dietary sodium intake, blood pressure and cardiovascular event. Diverse questionnaire and 24 hour urinary sodium measurement are used to estimate sodium intake. Complete reflection of eating and cooking habits to the dietary survey method is difficult. Furthermore, the differences of database between countries make it difficult to compare the amount of sodium intake between countries. It is also difficult to consider individual variation of cooking and eating habits. Due to limitations of dietary survey method, WHO recommended 24 hour urinary sodium measurement to estimated sodium intake in the population survey, and many countries are adopting. However, in Korea National Health and Nutrition Examination Survey, only dietary survey method has been used.

The present survey study was designed 1) to test the feasibility of 24 hour urinary sodium measurement for the estimation of sodium intake (including percentage of complete 24 hour urine sample collection) in the population based study; 2) to establish feasible method of 24 hour urinary sodium measurement; 3) to compare 24 hour urinary sodium measurement to the dietary survey method; and 4) to estimate the sodium intake by 24 hour urinary sodium measurement in Goyang city general population (aged 20-70 years).

Study Overview

Status

Completed

Detailed Description

Measurements: should be performed for 2 days

  1. 24 hour urine Na, K and Creatinine, 24 hour urine amount

    1. Calculation of urine completeness index : Creatinine/(21 x Bwt)
    2. Definition of incomplete urine collection: complete index less than 0.7 and loss of urine more than one time or 100 mL
  2. 24 hour ambulatory blood pressure

    1. mobile-O-graph (IEM GmbH)
    2. measurement interval: 30 minutes
  3. Measurement of peripheral blood pressure : microlife WatchBP office

    1. Sitting position
    2. After 5 minutes resting
    3. Peripheral systolic BP (pSBP), Peripheral diastolic BP (pDBP),
  4. Central aortic blood pressure

    1. SphygmoCor (AtCor Medical, Australia)
    2. Central systolic blood pressure
  5. Pulse wave velocity

    1. VP2000 (Colin, Japan)
    2. pulse wave velocity (PWV): carotid-femoral Pulse Wave Velocity, heart-femoral Pulse Wave Velocity and brachial-ankle Pulse Wave Velocity
    3. distance measured by tape: distance from suprasternal notch to carotid artery, distance from suprasternal notch to femoral artery
    4. Silent environment
  6. Electrocardiography
  7. Blood chemistry and complete blood count

    1. Measure at the morning of first day after overnight fasting
    2. complete blood count, blood urea nitrogen/Creatinine, Fasting blood glucose, Total cholesterol, triglyceride, HDL cholesterol

Measurement protocol

  1. 1st day

    1. Visit hospital before 9:00 AM after overnight fasting
    2. Sampling of venous blood
    3. start 24 hour urine collection from 9:00 AM (with education for complete collection)
    4. start 24 hour ambulatory blood pressure monitoring, in parallel with 24 hour urine collection
  2. 2nd day

    1. Measure central aortic blood pressure
    2. Measure Pulse Wave Velocity
    3. Electrocardiography

Study Type

Observational

Enrollment (Actual)

620

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gyeonggi
      • Goyang, Gyeonggi, Korea, Republic of, 410-773
        • Clinical Trial Center, Dongguk University Ilsan Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

  1. Representative population of Goyang city who were randomly selected by digit dialing (RDD) method
  2. Volunteers who are reside in Goyang city

Description

Inclusion Criteria:

  • General population who are reside in Goyang city

Exclusion Criteria:

  • Urinary tract disease
  • Known chronic kidney disease
  • Unable to measure 24 hour ambulatory blood pressure measurement
  • Unable to collect 24 hour urine sample
  • Pregnancy
  • Alcoholics
  • Severe liver disease
  • Night workers
  • Mental retardation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
representitives of Goyang city
  1. Representative population of Goyang city who were randomly selected by digit dialing (RDD) method
  2. Volunteers who are reside in Goyang city

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sodium intake in a studied community
Time Frame: Cross-section
Sodium intake of a community population is measured by 24 hour urinary sodium excretion
Cross-section

Secondary Outcome Measures

Outcome Measure
Time Frame
The association between 24 hour urinary sodium excretion and ambulatory blood pressure
Time Frame: Cross-sectional
Cross-sectional

Other Outcome Measures

Outcome Measure
Time Frame
The relationship between ambulatory blood pressure variability and arterial stiffness
Time Frame: Cross-sectional
Cross-sectional

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Moo-Yong Rhee, MD, PhD, Clinical Trial Center, Dongguk University Ilsan Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Actual)

November 1, 2011

Study Completion (Actual)

November 1, 2011

Study Registration Dates

First Submitted

September 21, 2011

First Submitted That Met QC Criteria

September 21, 2011

First Posted (Estimate)

September 22, 2011

Study Record Updates

Last Update Posted (Estimate)

January 23, 2013

Last Update Submitted That Met QC Criteria

January 21, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • 11162KFDA162 (Other Grant/Funding Number: 11162KFDA162)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Population

3
Subscribe